Pacira BioSciences, Inc. Capital Reinvestment Ratio
Pacira BioSciences, Inc. capital reinvestment ratio. Pacira BioSciences, Inc. (PCRX) has a Capital Reinvestment Ratio of 0.02x as of June 2026, meaning it reinvests 0% of its operating cash flow ($57.46 Million) in capital expenditures ($1.34 Million). See Pacira BioSciences, Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Pacira BioSciences, Inc. (2014–2025)
Capital reinvestment ratio of Pacira BioSciences, Inc. from 2014 to 2025. This chart tracks Pacira BioSciences, Inc.'s Capital Reinvestment Ratio across 12 annual periods. See Pacira BioSciences, Inc. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Pacira BioSciences, Inc. Capital Reinvestment Ratio by Year (2014–2025)
Pacira BioSciences, Inc. capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see PCRX cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | $151.99 Million | $15.33 Million | ▲ +79.6% |
| 2024 | 0.06x | $189.39 Million | $10.64 Million | ▼ -42.7% |
| 2023 | 0.10x | $154.65 Million | $15.16 Million | ▼ -52.6% |
| 2022 | 0.21x | $145.27 Million | $30.08 Million | ▼ -43.3% |
| 2021 | 0.36x | $125.72 Million | $45.87 Million | ▼ -25.7% |
| 2020 | 0.49x | $77.03 Million | $37.80 Million | ▲ +240.6% |
| 2019 | 0.14x | $70.52 Million | $10.16 Million | ▼ -51.5% |
| 2018 | 0.30x | $48.87 Million | $14.51 Million | ▼ -72.6% |
| 2017 | 1.08x | $17.79 Million | $19.27 Million | ▲ +46.7% |
| 2016 | 0.74x | $33.45 Million | $24.71 Million | ▼ -48.1% |
| 2015 | 1.42x | $29.00 Million | $41.27 Million | ▲ +65.6% |
| 2014 | 0.86x | $25.47 Million | $21.89 Million | — |